<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37371554</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2218-273X</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>11</Day></PubDate></JournalIssue><Title>Biomolecules</Title><ISOAbbreviation>Biomolecules</ISOAbbreviation></Journal><ArticleTitle>Increased Serum Interleukin 10 Levels Are Associated with Increased Disease Activity and Increased Risk of Anti-SS-A/Ro Antibody Positivity in Patients with Systemic Lupus Erythematosus.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">974</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biom13060974</ELocationID><Abstract><AbstractText Label="UNLABELLED">Interleukin 10 (IL-10) plays a role in inflammation and cell-type responses. The anti-SS-A/Ro antibody contributes to leucopenia, and cutaneous and neonatal lupus.</AbstractText><AbstractText Label="OBJECTIVES">To evaluate the association between serum IL-10 levels and autoantibodies, disease activity and organ involvement in systemic lupus erythematosus (SLE) patients.</AbstractText><AbstractText Label="PATIENTS AND METHODS">We studied 200 SLE patients and 50 controls. We analyzed organ involvement, disease activity, serum IL-10 and interleukin-6 (IL-6) levels, and antinuclear and antiphospholipid antibody profiles.</AbstractText><AbstractText Label="RESULTS">Serum IL-10 and IL-6 levels were higher in SLE patients than in controls (all <i>p</i> &lt; 0.00001). Serum IL-10 levels were positively correlated with IL-6 (<i>p</i> &lt; 0.00001), CRP (<i>p</i> &lt; 0.00001), fibrinogen (<i>p</i> = 0.003), and ESR (<i>p</i> &lt; 0.00001), and negatively correlated with hemoglobin (<i>p</i> = 0.0004) and lymphocytes (<i>p</i> = 0.01). Serum IL-6 levels were positively correlated with CRP (<i>p</i> &lt; 0.00001), fibrinogen (<i>p</i> = 0.001), and ESR (<i>p</i> &lt; 0.00001); and negatively correlated with hemoglobin (<i>p</i> = 0.008) and lymphocytes (<i>p</i> = 0.03). Elevated serum IL-10 levels were associated with an increased risk of anti-SS-A/Ro antibody positivity (<i>p</i> = 0.03). Elevated serum IL-6 levels were associated with an increased risk of heart (<i>p</i> = 0.007) and lung (<i>p</i> = 0.04) involvement.</AbstractText><AbstractText Label="CONCLUSIONS">In SLE patients, increased serum IL-10 levels were associated with increased disease activity and risk of anti-SS-A/Ro antibody positivity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Winikajtis-Burzy&#x144;ska</LastName><ForeName>Agnieszka</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Individual Laboratory for Rheumatologic Diagnostics, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, 71-252 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brzosko</LastName><ForeName>Marek</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Internal Medicine, Geriatrics and Clinical Immunology, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, 71-252 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Przepiera-B&#x119;dzak</LastName><ForeName>Hanna</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-6727-2594</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology, Internal Medicine, Geriatrics and Clinical Immunology, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, 71-252 Szczecin, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomolecules</MedlineTA><NlmUniqueID>101596414</NlmUniqueID><ISSNLinking>2218-273X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>130068-27-8</RegistryNumber><NameOfSubstance UI="D016753">Interleukin-10</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="Y">Autoantibodies</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016753" MajorTopicYN="Y">Interleukin-10</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="Y">Interleukin-6</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007970" MajorTopicYN="N">Leukopenia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">IL-10</Keyword><Keyword MajorTopicYN="N">IL-6</Keyword><Keyword MajorTopicYN="N">anti-SS-A/Ro antibodies</Keyword><Keyword MajorTopicYN="N">disease activity</Keyword><Keyword MajorTopicYN="N">organ involvement</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>28</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37371554</ArticleId><ArticleId IdType="pmc">PMC10296207</ArticleId><ArticleId IdType="doi">10.3390/biom13060974</ArticleId><ArticleId IdType="pii">biom13060974</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hedrich C.M. Epigenetics in SLE. Curr. Rheumatol. Rep. 2017;19:58. doi: 10.1007/s11926-017-0685-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-017-0685-1</ArticleId><ArticleId IdType="pmc">PMC5532407</ArticleId><ArticleId IdType="pubmed">28752494</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomczyk-Socha M., Sikorska-Szaflik H., Frankowski M., Andrzejewska K., Odziomek A., Szmyrka M. Clinical and Immunological Characteristics of Polish Patients with Systemic Lupus Erythematosus. Adv. Clin. Exp. Med. 2018;27:57&#x2013;61. doi: 10.17219/acem/65860.</Citation><ArticleIdList><ArticleId IdType="doi">10.17219/acem/65860</ArticleId><ArticleId IdType="pubmed">29521043</ArticleId></ArticleIdList></Reference><Reference><Citation>Rees F., Doherty M., Grainge M., Davenport G., Lanyon P., Zhang W. The Incidence and Prevalence of Systemic Lupus Erythematosus in the UK, 1999&#x2013;2012. Ann. Rheum. Dis. 2016;75:136&#x2013;141. doi: 10.1136/annrheumdis-2014-206334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2014-206334</ArticleId><ArticleId IdType="pmc">PMC4717400</ArticleId><ArticleId IdType="pubmed">25265938</ArticleId></ArticleIdList></Reference><Reference><Citation>Talaat R.M., Mohamed S.F., Bassyouni I.H., Raouf A.A. Th1/Th2/Th17/Treg Cytokine Imbalance in Systemic Lupus Erythematosus (SLE) Patients: Correlation with Disease Activity. Cytokine. 2015;72:146&#x2013;153. doi: 10.1016/j.cyto.2014.12.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2014.12.027</ArticleId><ArticleId IdType="pubmed">25647269</ArticleId></ArticleIdList></Reference><Reference><Citation>Song K., Liu L., Zhang X., Chen X. An Update on Genetic Susceptibility in Lupus Nephritis. Clin. Immunol. 2020;210:108272. doi: 10.1016/j.clim.2019.108272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2019.108272</ArticleId><ArticleId IdType="pubmed">31683055</ArticleId></ArticleIdList></Reference><Reference><Citation>Stannard J.N., Kahlenberg J.M. Cutaneous Lupus Erythematosus: Updates on Pathogenesis and Associations with Systemic Lupus. Curr. Opin. Rheumatol. 2016;28:453&#x2013;459. doi: 10.1097/BOR.0000000000000308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000308</ArticleId><ArticleId IdType="pmc">PMC4965280</ArticleId><ArticleId IdType="pubmed">27270345</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones B.G., Penkert R.R., Surman S.L., Sealy R.E., Pelletier S., Xu B., Neale G., Maul R.W., Gearhart P.J., Hurwitz J.L. Matters of Life and Death: How Estrogen and Estrogen Receptor Binding to the Immunoglobulin Heavy Chain Locus May Influence Outcomes of Infection, Allergy, and Autoimmune Disease. Cell. Immunol. 2019;346:103996. doi: 10.1016/j.cellimm.2019.103996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellimm.2019.103996</ArticleId><ArticleId IdType="pmc">PMC7368653</ArticleId><ArticleId IdType="pubmed">31703914</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy E.M., Smith S., Lee R.Z., Cunnane G., Doran M.F., Donnelly S., Howard D., O&#x2019;Connell P., Kearns G., Ni Gabhann J., et al. The Association of Cytokines with Disease Activity and Damage Scores in Systemic Lupus Erythematosus Patients. Rheumatology. 2014;53:1586&#x2013;1594. doi: 10.1093/rheumatology/ket428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/ket428</ArticleId><ArticleId IdType="pubmed">24706988</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson S.W., Kolhatkar N.S., Rawlings D.J. B Cells Take the Front Seat: Dysregulated B Cell Signals Orchestrate Loss of Tolerance and Autoantibody Production. Curr. Opin. Immunol. 2015;33:70&#x2013;77. doi: 10.1016/j.coi.2015.01.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2015.01.018</ArticleId><ArticleId IdType="pmc">PMC4397155</ArticleId><ArticleId IdType="pubmed">25679954</ArticleId></ArticleIdList></Reference><Reference><Citation>Su&#xe1;rez-Fueyo A., Bradley S.J., Tsokos G.C. T Cells in Systemic Lupus Erythematosus. Curr. Opin. Immunol. 2016;43:32&#x2013;38. doi: 10.1016/j.coi.2016.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2016.09.001</ArticleId><ArticleId IdType="pmc">PMC5125867</ArticleId><ArticleId IdType="pubmed">27636649</ArticleId></ArticleIdList></Reference><Reference><Citation>Su D.-L., Lu Z.-M., Shen M.-N., Li X., Sun L.-Y. Roles of Pro- and Anti-Inflammatory Cytokines in the Pathogenesis of SLE. J. Biomed. Biotechnol. 2012;2012:347141. doi: 10.1155/2012/347141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/347141</ArticleId><ArticleId IdType="pmc">PMC3303597</ArticleId><ArticleId IdType="pubmed">22500087</ArticleId></ArticleIdList></Reference><Reference><Citation>Adhia A.H. The Cytokine Genetic Polymorphism of Interleukin-10 and Interleukin-12 in Systemic Lupus Erythematosus Disease. Mustansiriya Med. 2015;14:17&#x2013;21.</Citation></Reference><Reference><Citation>Hedrich C.M., Bream J.H. Cell Type-Specific Regulation of IL-10 Expression in Inflammation and Disease. Immunol. Res. 2010;47:185&#x2013;206. doi: 10.1007/s12026-009-8150-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-009-8150-5</ArticleId><ArticleId IdType="pmc">PMC2892196</ArticleId><ArticleId IdType="pubmed">20087682</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyer S.S., Cheng G. Role of Interleukin 10 Transcriptional Regulation in Inflammation and Autoimmune Disease. Crit. Rev. Immunol. 2012;32:23&#x2013;63. doi: 10.1615/CritRevImmunol.v32.i1.30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1615/CritRevImmunol.v32.i1.30</ArticleId><ArticleId IdType="pmc">PMC3410706</ArticleId><ArticleId IdType="pubmed">22428854</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H., Hu B., Huang N., Mo X., Li W., Zhang B., Wei B., Gao M., Wang Y., Liu X., et al. Aberrant T Cell Subsets and Cytokines Expression Profile in Systemic Lupus Erythematosus. Clin. Rheumatol. 2018;37:2405&#x2013;2413. doi: 10.1007/s10067-018-4124-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-018-4124-0</ArticleId><ArticleId IdType="pubmed">29785672</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin Z., Huang J., He W., Cao Z., Luo X., Zhang C., Ye Z. Serum Level of Eight Cytokines in Han Chinese Patients with Systemic Lupus Erythematosus Using Multiplex Fluorescent Microsphere Method. Cent. Eur. J. Immunol. 2014;39:228&#x2013;235. doi: 10.5114/ceji.2014.43728.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/ceji.2014.43728</ArticleId><ArticleId IdType="pmc">PMC4440016</ArticleId><ArticleId IdType="pubmed">26155129</ArticleId></ArticleIdList></Reference><Reference><Citation>Elazeem M., Mohammed R., Abdallah N. Correlation of Serum Interleukin-10 Level with Disease Activity and Severity in Systemic Lupus Erythematosus. Egypt. Rheumatol. Rehabil. 2018;45:25. doi: 10.4103/err.err_15_17.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/err.err_15_17</ArticleId></ArticleIdList></Reference><Reference><Citation>Abou El-Fetouh S., Mohammed R.H.A., Abozaid H.S.M. Serum Interleukin-18 and Interleukin-10 Levels in Systemic Lupus Erythematosus: Correlation with SLEDAI Score and Disease Activity Parameters. Egypt. Rheumatol. Rehabil. 2014;41:160&#x2013;166. doi: 10.4103/1110-161X.147358.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1110-161X.147358</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena A., Khosraviani S., Noel S., Mohan D., Donner T., Hamad A.R.A. Interleukin-10 Paradox: A Potent Immunoregulatory Cytokine That Has Been Difficult to Harness for Immunotherapy. Cytokine. 2015;74:27&#x2013;34. doi: 10.1016/j.cyto.2014.10.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2014.10.031</ArticleId><ArticleId IdType="pmc">PMC4454631</ArticleId><ArticleId IdType="pubmed">25481648</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisetsky D.S. Evolving Story of Autoantibodies in Systemic Lupus Erythematosus. J. Autoimmun. 2020;110:102356. doi: 10.1016/j.jaut.2019.102356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2019.102356</ArticleId><ArticleId IdType="pmc">PMC8284812</ArticleId><ArticleId IdType="pubmed">31810857</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggarwal A. Role of Autoantibody Testing. Best Pract. Res. Clin. Rheumatol. 2014;28:907&#x2013;920. doi: 10.1016/j.berh.2015.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.berh.2015.04.010</ArticleId><ArticleId IdType="pubmed">26096093</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J.L., Black S.M., Chong B.F. Role of Biomarkers in the Diagnosis and Prognosis of Patients with Cutaneous Lupus Erythematosus. Ann. Transl. Med. 2021;9:429. doi: 10.21037/atm-20-5232.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm-20-5232</ArticleId><ArticleId IdType="pmc">PMC8033322</ArticleId><ArticleId IdType="pubmed">33842650</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer-Betz R., Specker C. Pregnancy in Systemic Lupus Erythematosus and Antiphospholipid Syndrome. Best. Pract. Res. Clin. Rheumatol. 2017;31:397&#x2013;414. doi: 10.1016/j.berh.2017.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.berh.2017.09.011</ArticleId><ArticleId IdType="pubmed">29224680</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M., Orbai A.-M., Alarc&#xf3;n G.S., Gordon C., Merrill J.T., Fortin P.R., Bruce I.N., Isenberg D., Wallace D.J., Nived O., et al. Derivation and Validation of the Systemic Lupus International Collaborating Clinics Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheum. 2012;64:2677&#x2013;2686. doi: 10.1002/art.34473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.34473</ArticleId><ArticleId IdType="pmc">PMC3409311</ArticleId><ArticleId IdType="pubmed">22553077</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikdashi J., Nived O. Measuring Disease Activity in Adults with Systemic Lupus Erythematosus: The Challenges of Administrative Burden and Responsiveness to Patient Concerns in Clinical Research. Arthritis. Res. Ther. 2015;17:183. doi: 10.1186/s13075-015-0702-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-015-0702-6</ArticleId><ArticleId IdType="pmc">PMC4507322</ArticleId><ArticleId IdType="pubmed">26189728</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., Derksen R.H.W.M., DE Groot P.G., Koike T., Meroni P.L., et al. International Consensus Statement on an Update of the Classification Criteria for Definite Antiphospholipid Syndrome (APS) J. Thromb. Haemost. 2006;4:295&#x2013;306. doi: 10.1111/j.1538-7836.2006.01753.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2006.01753.x</ArticleId><ArticleId IdType="pubmed">16420554</ArticleId></ArticleIdList></Reference><Reference><Citation>Guimar&#xe3;es P.M., Scavuzzi B.M., Stadtlober N.P., Franchi Santos L.F.D.R., Lozovoy M.A.B., Iriyoda T.M.V., Costa N.T., Reiche E.M.V., Maes M., Dichi I., et al. Cytokines in Systemic Lupus Erythematosus: Far beyond Th1/Th2 Dualism Lupus: Cytokine Profiles. Immunol. Cell. Biol. 2017;95:824&#x2013;831. doi: 10.1038/icb.2017.53.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/icb.2017.53</ArticleId><ArticleId IdType="pubmed">28649995</ArticleId></ArticleIdList></Reference><Reference><Citation>Dima A., Pricopi I., Balanescu E., Balanescu P., Baicus C. Interleukin 10 Related to Lymphopenia in Lupus. Eur. J. Intern. Med. 2019;64:e9&#x2013;e10. doi: 10.1016/j.ejim.2019.04.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2019.04.012</ArticleId><ArticleId IdType="pubmed">31036439</ArticleId></ArticleIdList></Reference><Reference><Citation>Park Y.B., Lee S.K., Kim D.S., Lee J., Lee C.H., Song C.H. Elevated Interleukin-10 Levels Correlated with Disease Activity in Systemic Lupus Erythematosus. Clin. Exp. Rheumatol. 1998;16:283&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pubmed">9631750</ArticleId></ArticleIdList></Reference><Reference><Citation>Houssiau F.A., Lefebvre C., Vanden Berghe M., Lambert M., Devogelaer J.P., Renauld J.C. Serum Interleukin 10 Titers in Systemic Lupus Erythematosus Reflect Disease Activity. Lupus. 1995;4:393&#x2013;395. doi: 10.1177/096120339500400510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/096120339500400510</ArticleId><ArticleId IdType="pubmed">8563734</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-S&#xe1;nchez N., P&#xe9;rez-Pinto S., Robles-Marhuenda &#xc1;., Arnalich-Fern&#xe1;ndez F., Mart&#xed;n Came&#xe1;n M., Hueso Zalvide E., Bartha J.L. Obstetric and Perinatal Outcome in Anti-Ro/SSA-Positive Pregnant Women: A Prospective Cohort Study. Immunol. Res. 2017;65:487&#x2013;494. doi: 10.1007/s12026-016-8888-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-016-8888-5</ArticleId><ArticleId IdType="pubmed">28138914</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz T., Dominguez D., Jaeggi E., Knight A.M., Laskin C.A., Ng L., Silverio F., Silverman E.D., Hiraki L.T. Ethnicity and Neonatal Lupus Erythematosus Manifestations Risk in a Large Multiethnic Cohort. J. Rheumatol. 2021;48:1417&#x2013;1421. doi: 10.3899/jrheum.201338.</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.201338</ArticleId><ArticleId IdType="pubmed">33795326</ArticleId></ArticleIdList></Reference><Reference><Citation>Dima A., Jurcut C., Balanescu P., Balanescu E., Badea C., Caraiola S., Miler I., Ramba D., Ionescu R., Baicus C., et al. Clinical Significance of Serum and Urinary Interleukin-6 in Systemic Lupus Erythematosus Patients. Egypt. Rheumatol. 2017;39:1&#x2013;6. doi: 10.1016/j.ejr.2016.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejr.2016.05.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Umare V., Pradhan V., Nadkar M., Rajadhyaksha A., Patwardhan M., Ghosh K.K., Nadkarni A.H. Effect of Proinflammatory Cytokines (IL-6, TNF-&#x3b1;, and IL-1&#x3b2;) on Clinical Manifestations in Indian SLE Patients. Mediat. Inflamm. 2014;2014:385297. doi: 10.1155/2014/385297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/385297</ArticleId><ArticleId IdType="pmc">PMC4273527</ArticleId><ArticleId IdType="pubmed">25548434</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen H.J., Pieper C.F., Harris T., Rao K.M., Currie M.S. The Association of Plasma IL-6 Levels with Functional Disability in Community-Dwelling Elderly. J. Gerontol. A.Biol. Sci. Med. Sci. 1997;52:M201&#x2013;M208. doi: 10.1093/gerona/52A.4.M201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/52A.4.M201</ArticleId><ArticleId IdType="pubmed">9224431</ArticleId></ArticleIdList></Reference><Reference><Citation>Morley J.E., Baumgartner R.N. Cytokine-Related Aging Process. J. Gerontol. A. Biol. Sci. Med. Sci. 2004;59:M924&#x2013;M929. doi: 10.1093/gerona/59.9.M924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/59.9.M924</ArticleId><ArticleId IdType="pubmed">15472157</ArticleId></ArticleIdList></Reference><Reference><Citation>Macci&#xf2; A., Madeddu C. Management of Anemia of Inflammation in the Elderly. Anemia. 2012;2012:e563251. doi: 10.1155/2012/563251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/563251</ArticleId><ArticleId IdType="pmc">PMC3471391</ArticleId><ArticleId IdType="pubmed">23091709</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci L., Corsi A., Lauretani F., Bandinelli S., Bartali B., Taub D.D., Guralnik J.M., Longo D.L. The Origins of Age-Related Proinflammatory State. Blood. 2005;105:2294&#x2013;2299. doi: 10.1182/blood-2004-07-2599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2004-07-2599</ArticleId><ArticleId IdType="pmc">PMC9828256</ArticleId><ArticleId IdType="pubmed">15572589</ArticleId></ArticleIdList></Reference><Reference><Citation>Watad A., Bragazzi N.L., Adawi M., Amital H., Toubi E., Porat B.-S., Shoenfeld Y. Autoimmunity in the Elderly: Insights from Basic Science and Clinics&#x2014;A Mini-Review. GER. 2017;63:515&#x2013;523. doi: 10.1159/000478012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000478012</ArticleId><ArticleId IdType="pubmed">28768257</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Shafey A.M., Kamel L.M., Fikry A.A., Nasr M.M., Abdel Galil S.M. Serum Hepcidin and Interleukin-6 in Systemic Lupus Erythematosus Patients: Crucial Factors for Correction of Anemia. Egypt. Rheumatol. Rehabil. 2020;47:14. doi: 10.1186/s43166-020-00006-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43166-020-00006-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdel Galil S.M., Ezzeldin N., El-Boshy M.E. The Role of Serum IL-17 and IL-6 as Biomarkers of Disease Activity and Predictors of Remission in Patients with Lupus Nephritis. Cytokine. 2015;76:280&#x2013;287. doi: 10.1016/j.cyto.2015.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2015.05.007</ArticleId><ArticleId IdType="pubmed">26073684</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang D.-H. The Biological Effects of Interleukin-6 and Their Clinical Applications in Autoimmune Diseases and Cancers. Rheum. Acta Open Access. 2017;1:6&#x2013;16. doi: 10.17352/raoa.000003.</Citation><ArticleIdList><ArticleId IdType="doi">10.17352/raoa.000003</ArticleId></ArticleIdList></Reference><Reference><Citation>Cigni A., Pileri P.V., Faedda R., Gallo P., Sini A., Satta A.E., Marras R., Carta E., Argiolas D., Rum I., et al. Interleukin 1, Interleukin 6, Interleukin 10, and Tumor Necrosis Factor &#x3b1; in Active and Quiescent Systemic Lupus Erythematosus. J. Investig. Med. 2014;62:825&#x2013;829. doi: 10.2310/JIM.0000000000000085.</Citation><ArticleIdList><ArticleId IdType="doi">10.2310/JIM.0000000000000085</ArticleId><ArticleId IdType="pubmed">24987977</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin S., Yu C., Yu B. Changes of Serum IL-6, IL-10 and TNF-&#x3b1; Levels in Patients with Systemic Lupus Erythematosus and Their Clinical Value. Am. J. Transl. Res. 2021;13:2867&#x2013;2874.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129414</ArticleId><ArticleId IdType="pubmed">34017450</ArticleId></ArticleIdList></Reference><Reference><Citation>Lao X., Ma L., Ma Q., Ma Q., Yang Z., Guo L., Nong W. Hematological Factors Associated with Immunity, Inflammation, and Metabolism in Patients with Systemic Lupus Erythematosus: Data from a Zhuang Cohort in Southwest China. J. Clin. Lab. Anal. 2020;34:e23211. doi: 10.1002/jcla.23211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.23211</ArticleId><ArticleId IdType="pmc">PMC7307337</ArticleId><ArticleId IdType="pubmed">31978275</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinlan C., Marks S.D., Tullus K. Why Are Kids with Lupus at an Increased Risk of Cardiovascular Disease? Pediatr. Nephrol. 2016;31:861&#x2013;883. doi: 10.1007/s00467-015-3202-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00467-015-3202-7</ArticleId><ArticleId IdType="pubmed">26399239</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain D., Halushka M.K. Cardiac Pathology of Systemic Lupus Erythematosus. J. Clin. Pathol. 2009;62:584&#x2013;592. doi: 10.1136/jcp.2009.064311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jcp.2009.064311</ArticleId><ArticleId IdType="pubmed">19561227</ArticleId></ArticleIdList></Reference><Reference><Citation>Choy E., Rose-John S. Interleukin-6 as a Multifunctional Regulator: Inflammation, Immune Response, and Fibrosis. J. Scleroderma Relat. Disord. 2017;2((Suppl. S2)):S1&#x2013;S5. doi: 10.5301/jsrd.5000265.</Citation><ArticleIdList><ArticleId IdType="doi">10.5301/jsrd.5000265</ArticleId></ArticleIdList></Reference><Reference><Citation>McElvaney O.J., Curley G.F., Rose-John S., McElvaney N.G. Interleukin-6: Obstacles to Targeting a Complex Cytokine in Critical Illness. Lancet Respir. Med. 2021;9:643&#x2013;654. doi: 10.1016/S2213-2600(21)00103-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00103-X</ArticleId><ArticleId IdType="pmc">PMC8051931</ArticleId><ArticleId IdType="pubmed">33872590</ArticleId></ArticleIdList></Reference><Reference><Citation>du Toit R., Reuter H., Walzl G., Snyders C., Chegou N.N., Herbst P.G., Doubell A.F. Serum Cytokine Levels Associated with Myocardial Injury in Systemic Lupus Erythematosus. Rheumatology. 2021;60:2010&#x2013;2021. doi: 10.1093/rheumatology/keaa540.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa540</ArticleId><ArticleId IdType="pubmed">33221897</ArticleId></ArticleIdList></Reference><Reference><Citation>Tentolouris C., Tousoulis D., Antoniades C., Bosinakou E., Kotsopoulou M., Trikas A., Toutouzas P., Stefanadis C. Endothelial Function and Proinflammatory Cytokines in Patients with Ischemic Heart Disease and Dilated Cardiomyopathy. Int. J. Cardiol. 2004;94:301&#x2013;305. doi: 10.1016/j.ijcard.2003.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2003.08.002</ArticleId><ArticleId IdType="pubmed">15093997</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedves M., K&#xf3;sa F., Kunovszki P., Tak&#xe1;cs P., Szab&#xf3; M.Z., Karyekar C., Lofland J.H., Nagy G. Large-Scale Mortality Gap between SLE and Control Population Is Associated with Increased Infection-Related Mortality in Lupus. Rheumatology. 2020;59:3443&#x2013;3451. doi: 10.1093/rheumatology/keaa188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa188</ArticleId><ArticleId IdType="pmc">PMC7590419</ArticleId><ArticleId IdType="pubmed">32357240</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>